Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8 USD | -6.98% | -5.55% | +147.68% |
Apr. 10 | Arcutis Biotherapeutics, Inc. Announces Chief Financial Officer Changes | CI |
Mar. 18 | Arcutis Biotherapeutics, Inc.(NasdaqGS:ARQT) added to S&P Biotechnology Select Industry Index | CI |
Financials (USD)
Sales 2024 * | 117M | Sales 2025 * | 234M | Capitalization | 924M |
---|---|---|---|---|---|
Net income 2024 * | -229M | Net income 2025 * | -143M | EV / Sales 2024 * | 5.91 x |
Net cash position 2024 * | 231M | Net cash position 2025 * | 228M | EV / Sales 2025 * | 2.98 x |
P/E ratio 2024 * |
-3.36
x | P/E ratio 2025 * |
-6.38
x | Employees | 296 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.52% |
Latest transcript on Arcutis Biotherapeutics, Inc.
1 day | -6.98% | ||
1 week | -5.55% | ||
Current month | -3.85% | ||
1 month | -25.58% | ||
3 months | +31.80% | ||
6 months | +227.87% | ||
Current year | +147.68% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 55 | 15-12-31 |
Rajvir Madan
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-31 |
Jay Ramsinghani
COO | Chief Operating Officer | - | 20-05-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Heron
CHM | Chairman | 53 | 16-03-31 |
Founder | 69 | 16-05-31 | |
Keith Leonard
BRD | Director/Board Member | 62 | 21-09-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 8 | -6.98% | 2,596,520 |
24-05-02 | 8.6 | -2.71% | 1,735,706 |
24-05-01 | 8.84 | +6.25% | 2,797,138 |
24-04-30 | 8.32 | -5.24% | 1,757,946 |
24-04-29 | 8.78 | +3.66% | 2,117,891 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+147.68% | 924M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- ARQT Stock